References

1. Kirfel, J.; Magin, T.M.; Reichelt, J. Keratins: A structural scaffold with emerging functions. Cell. Mol. Life Sci. 2003, 60, 56.

2. Irvine, A.D.; McLean, W.H. Human keratin diseases: The increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br. J. Dermatol. 1999, 140, 815.

3. Whittock, N.V.; Eady, R.A.; McGrath, J.A. Genomic organization and amplification of the human epidermal type II keratin genes K1 and K5. Biochem. Biophys. Res. Commun. 2000, 274, 149.

4. Smith, F.J.; Maingi, C.; Covello, S.P.; Higgins, C.; Schmidt, M.; Lane, E.B.; Uitto, J.; Leigh, I.M.; McLean, W.H. Genomic organization and fine mapping of the keratin 2e gene (KRT2E): K2e V1 domain polymorphism and novel mutations in ichthyosis bullosa of Siemens. J. Invest. Dermatol. 1998, 111, 817.

5. Irvine, A.D.; Corden, L.D.; Swensson, O.; Swensson, B.; Moore, J.E.; Frazer, D.G.; Smith, F.J.; Knowlton, R.G.; Christophers, E.; Rochels, R.; Uitto, J.; McLean, W.H. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat. Genet. 1997, 16, 184.

6. Rugg, E.L.; McLean, W.H.; Allison, W.E.; Lunny, D.P.; Macleod, R.I.; Felix, D.H.; Lane, E.B.; Munro, C.S. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat. Genet. 1995, 11, 450.

7. Smith, F.J.; McKenna, K.E.; Irvine, A.D.; Bingham, E.A.; Coleman, C.M.; Uitto, J.; McLean, W.H. A mutation detection strategy for the human keratin 6A gene and novel missense mutations in two cases of pachyonychia con-genita type 1. Exp. Dermatol. 1999, 8, 109.

8. Smith, F.J.; Jonkman, M.F.; van Goor, H.; Coleman, C.M.; Covello, S.P.; Uitto, J.; McLean, W.H. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum. Mol. Genet. 1998, 7, 1143.

9. Ku, N.O.; Gish, R.; Wright, T.L.; Omary, M.B. Keratin 8 mutations in patients with cryptogenic liver disease. N. Engl. J. Med. 2001, 344, 1580.

10. Reis, A.; Hennies, H.C.; Langbein, L.; Digweed, M.; Mischke, D.; Drechsler, M.; Schrock, E.; Royer-Pokora, B.; Franke, W.W.; Sperling, K.; Kuster, W. Keratin 9 gene mutations in epidermolytic palmoplanar keratoderma (EPPK). Nat. Genet. 1994, 6, 174.

11. Chipev, C.C.; Yang, J.M.; DiGiovanna, J.J.; Steinert, P.M.; 24. Marekov, L.; Compton, J.G.; Bale, S.J. Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am. J. Hum. Genet. 1994, 54, 179.

12. Nishida, K.; Honma, Y.; Dota, A.; Kawasaki, S.; Adachi, 25. W.; Nakamura, T.; Quantock, A.J.; Hosotani, H.; Yamamoto, S.; Okada, M.; Shimomura, Y.; Kinoshita,

S. Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy. Am. J. Hum. Genet. 1997, 61, 1268. 26.

13. Richard, G.; De Laurenzi, V.; Didona, B.; Bale, S.J.; Compton, J.G. Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat. Genet. 1995, 11, 453.

14. Wood, P.; Baty, D.U.; Lane, E.B.; McLean, W.H. Longrange polymerase chain reaction for specific full-length 27. amplification of the human keratin 14 gene and novel keratin 14 mutations in epidermolysis bullosa simplex patients. J. Invest. Dermatol. 2003, 120, 495. 28.

15. Smith, F.J.; McKusick, V.A.; Nielsen, K.; Pfendner, E.; Uitto, J.; McLean, W.H. Cloning of multiple keratin 16 genes facilities prenatal diagnosis of pachyonychia con-genita type 1. Prenat. Diagn. 1999, 19, 941.

16. McLean, W.H.; Rugg, E.L.; Lunny, D.P.; Morley, S.M.; 29. Lane, E.B.; Swensson, O.; Dopping-Hepenstal, P.J. Griffiths, W.A.; Eady, R.A.; Higgins, C.; Nasvaria, H.A. Leigh, I.M.; Strachan, T.; Kunkeler, L.; Munro, C.S. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat. Genet. 1995, 9, 273. 30.

17. Winter, H.; Rogers, M.A.; Langbein, L.; Stevens, H.P.; Leigh, I.M.; Labreze, C.; Roul, S.; Taieb, A.; Krieg, T.; Schweizer, J. Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat. Genet.

18. Chapalian, V.; Winter, H.; Langbein, L.; Le Roy, J.M.; Labreze, C.; Nikolic, M.; Schweizer, J.; Taieb, A. Is the loose anagen hair syndrome a keratin disorder? A clinical and molecular study. Arch. Dermatol. 2002, 138,

19. Uitto, J.; Pulkkinen, L. Molecular genetics of heritable blistering disorders. Arch. Dermatol. 2001, 137, 1458.

20. Porter, R.M.; Lane, E.B. Phenotypes, genotypes and their contribution to understanding keratin function. Trends 33. Genet. 2003, 19, 278.

21. Ciubotaru, D.; Bergman, R.; Baty, D.; Indelman, M.; Pfendner, E.; Petronius, D.; Moualem, H.; Kanaan, M.; 34. Ben Amitai, D.; McLean, W.H.; Uitto, J.; Sprecher, E. Epidermolysis bullosa simplex in Israel: Clinical and genetic features. Arch. Dermatol. 2003, 139, 498.

22. Sprecher, E.; Yosipovitch, G.; Bergman, R.; Ciubutaro, D.; Indelman, M.; Pfendner, E.; Goh, L.C.; Miller, C.J.; Uitto, 35. J.; Richard, G. Epidermolytic hyperkeratosis and epider-molysis bullosa simplex caused by frameshift mutations altering the v2 tail domains of keratin 1 and keratin 5. J.

Invest. Dermatol. 2003, 120, 623. 36.

23. Gu, L.H.; Kim, S.C.; Ichiki, Y.; Park, J.; Nagai, M.; Kitajima, Y. A usual frameshift and delayed termination codon mutation in keratin 5 causes a novel type of epidermolysis bullosa simplex with migratory circinate erythema. J. Invest. Dermatol. 2003, 121, 482. Jonkman, M.F.; Pas, H.H.; Nijenhuis, M.; Kloosterhuis, G.; Steege, G. Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex. J. Invest. Dermatol. 2002, 119, 1275.

Koss-Harnes, D.; Hoyheim, B.; Anton-Lamprecht, I.; Gjesti, A.; Jorgenses, R.S.; Jahnsen, F.L.; Olaisen, B.; Wiche, G.; Gedde-Dahl, T. A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: Two identical de novo mutations. J. Invest. Dermatol.

Huber, M.; Floeth, M.; Borradori, L.; Schacke, H.; Rugg,

E.L.; Lane, E.B.; Frenk, E.; Hohl, D.; Bruckner-Tuderman, L. Deletion of the cytoplasmatic domain of BP180/ collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex. J. Invest. Dermatol. 2002, 118, 185.

DiGiovanna, J.J.; Bale, S.J. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch. Dermatol. 1994, 130, 1026.

Virtanen, M.; Gedde-Dahl, T.; Mork, N.J.; Leigh, I.; Bowden, P.E.; Vahlquist, A. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm. Venereol. 2001, 81, 163.

Terrinoni, A.; Puddu, P.; Didona, B.; De Laurenzi, V.; Candi, E.; Smith, F.J.; McLean, W.H.; Melino, G. A mutation in the V1 domain of K16 is responsible for unilateral palmoplantar verrucous nevus. J. Invest. Derma-tol. 2000, 114, 1136.

Ward, K.M.; Cook-Bolden, F.E.; Christiano, A.M.; Celebi, J.T. Identification of a recurrent mutation in keratin 6a in a patient with overlapping clinical features of pachyonychia congenita types 1 and 2. Clin. Exp. Dermatol. 2003, 28, 434.

Winter, H.; Labreze, C.; Chapalain, V.; Surleve-Bazeille, J.E.; Mercier, M.; Rogers, M.A.; Taieb, A.; Schweizer, J. A variable monilethrix phenotype associated with a novel mutation, glu402lys, in the helix termination motif of the II hair keratin hHb1. J. Invest. Dermatol. 1998, 111, 169. Vulpe, C.; Levinson, B.; Whitney, S.; Packman, S.; Gitschier, J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 1993, 3, 7.

Gupta, S.K.; Hodge, W.G. A new clinical perspective of corneal dystrophies through molecular genetics. Curr. Opin. Ophthalmol. 1999, 10, 234.

Ku, N.O.; Darling, J.M.; Krams, S.M.; Esquivel, C.O.; Keeffe, E.B.; Sibley, R.K.; Lee, Y.M.; Wright, T.L.; Omary, M.B. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. PNAS

Cavestro, G.M.; Frulloni, L.; Nouvenne, A.; Neri, T.M.; Calore, B.; Ferri, B.; Bovo, P.; Okolicsanyi, L.; Di Mario,

F.; Cavallini, G. Association of keratin 8 gene mutation with chronic pancreatitis. Dig. Liver Dis. 2003, 35, 416. Cao, T.; Longley, M.A.; Wang, X.J.; Roop, D.R. An inducible mouse model for epidermolysis bullosa simplex: Implications for gene therapy. J. Cell Biol. 2001, 152, 651.

How To Deal With Rosacea and Eczema

How To Deal With Rosacea and Eczema

Rosacea and Eczema are two skin conditions that are fairly commonly found throughout the world. Each of them is characterized by different features, and can be both discomfiting as well as result in undesirable appearance features. In a nutshell, theyre problems that many would want to deal with.

Get My Free Ebook


Post a comment